Lv53
848 积分 2026-04-08 加入
Antitumour immunity regulated by aberrant ERBB family signalling
2小时前
已完结
Bispecific antibodies for targeted delivery of anti-cancer therapeutic agents: A review
22小时前
已完结
Antibody–drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry
22小时前
已完结
Bispecific antibody–drug conjugates: a modular blueprint for next-generation cancer therapeutics
4天前
已完结
Bispecific antibodies for targeted delivery of anti-cancer therapeutic agents: A review
4天前
已完结
Perioperative Apalutamide in High-Risk Localized Prostate Cancer
7天前
已完结
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer
11天前
已完结
Anlotinib improves bile duct ligature‐induced liver fibrosis in rats via antiangiogenesis regulated by VEGFR2/mTOR pathway
1个月前
已完结
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
1个月前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
2个月前
已完结
皖公网安备34019202002308
